RecallDepth
Class III Terminated

BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150 mg, a) 30 count (NDC 59746- 758-30) & b) 90 count (NDC 59746-758-90) bottles, Rx only, Manufactured b Jubilant Generis Ltd, Roorkee, India, Marketed by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD

This recall has been terminated (originally issued March 13, 2019).

Company
Jubilant Cadista Pharmaceuticals, Inc.
Recall Initiated
February 28, 2019
Posted
March 13, 2019
Recall Number
D-0519-2019
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
a) 3,072 bottles; b) 2,688 bottles
Firm Location
Salisbury, MD, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications; 9-monthstability timepoint

Distribution

Product was distributed to one customer who may have further distributed the product.

Lot / Code Info

a) BR117002C, exp. date 11/2019; b) BR117003B and BR117004B, exp. date 11/2019

More recalls by Jubilant Cadista Pharmaceuticals, Inc.

View all recalls by this company →

Other recent Class III Drug recalls